1. Home
  2. JBI vs CDNA Comparison

JBI vs CDNA Comparison

Compare JBI & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Janus International Group Inc.

JBI

Janus International Group Inc.

HOLD

Current Price

$4.93

Market Cap

987.0M

Sector

Industrials

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$21.43

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JBI
CDNA
Founded
2002
1998
Country
United States
United States
Employees
N/A
765
Industry
Building Products
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
987.0M
1.1B
IPO Year
2021
2007

Fundamental Metrics

Financial Performance
Metric
JBI
CDNA
Price
$4.93
$21.43
Analyst Decision
Hold
Buy
Analyst Count
3
6
Target Price
$9.17
$28.00
AVG Volume (30 Days)
1.3M
744.0K
Earning Date
05-12-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.38
0.05
Revenue
N/A
$48,324,000.00
Revenue This Year
$9.36
$16.01
Revenue Next Year
$3.16
$11.31
P/E Ratio
$13.46
$430.00
Revenue Growth
N/A
18.93
52 Week Low
$4.75
$10.96
52 Week High
$10.80
$23.24

Technical Indicators

Market Signals
Indicator
JBI
CDNA
Relative Strength Index (RSI) 38.23 58.59
Support Level $4.86 $16.63
Resistance Level $5.76 $23.19
Average True Range (ATR) 0.23 1.46
MACD -0.02 -0.04
Stochastic Oscillator 48.85 66.57

Price Performance

Historical Comparison
JBI
CDNA

About JBI Janus International Group Inc.

Janus International Group Inc is a manufacturer and supplier of turnkey solutions for self-storage, commercial, and industrial building Solutions. The company provides products that include roll-up and swing doors, hallway systems, relocatable storage MASS (Moveable Additional Storage Structures) units, and technologies for automating facility and door operation. It is operated through two geographic regions; Janus North America and Janus International. The Janus International segment is comprised of a subsidiary whose production and sales are largely in Europe and Australia. The Janus North America segment is comprised of all the other entities.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: